Health Care News This Week
Medical News Print

Health Care News This Week

Executive Order to End Subsidies to Insurance Companies.  

President Trump signed an executive order ending cost-sharing subsidies to insurance companies, which were designed to help the insurance companies absorb costs associated with reducing out-of-pocket expenses for deductibles and co-payments for low-income customers.

But Wait. . . . .

  • A bi-partisan bill has been proposed to continue the cost-sharing subsidies for two years
  • And 19 states have asked a court to force the Trump administration to make these payments.

Google Map Controversy over Calories.  

You may have noticed that Google Maps added a calorie counter to its app showing you how many calories you would burn walking to your destination over driving.  Because of the controversy between eating disorders and calorie counting, this feature of Google Maps was removed.

Be Aware of Low-Cost/Low-Value Services.  

A recent study concludes that it’s not the big-dollar costs that are running up the cost of healthcare, but the low-cost (under $538), low-value services.  Depending on the person, low-value services include certain lab tests, imaging tests, EKG’s, scans and routine screenings.

“60 Minutes” and the Drug Enforcement Law.  

Last Sunday, “60 Minutes” and the Washington Post showed an exposé on a law that was unanimously approved by both the Senate and House and that weakens the Drug Enforcement Agency’s powers to reign in the opioid crisies.  As a result of this show, President Trump’s nominee to head the DEA withdrew his name from consideration. Many members of Congress expressed outrage and vowed to change the law.

Talcum Powder Cases.

A Missouri court tossed a $72 million verdict to a woman who claimed her use of Johnson & Johnson products containing talcum powder contributed to her ovarian cancer. This leaves the more than a thousand cases filed against Johnson & Johnson in doubt.

Have you ever missed your eye using eyedrops?  

A recent NPR story suggests that drug companies make the drops too big on purpose.  So the good news is you are probably not missing your eye.The bad news is the cost and waste associated with making the drops too big.

Share this article
Twitter icon
Facebook icon
Pinterest icon
LinkedIn icon